The group’s principle activities include developing and marketing novel products combining drugs, devices and biologics. The group's services include regulatory affairs, clinical trail design and management, database development and compliance, health economics, quality systems and compliances, biostatistics and venture capital due diligence. The group operates from United States, Mexico, Canada, Europe, China, Brazil and Korea.
